Vivoryon Therapeutics NV (VVY) — Financial Flexibility Index
Vivoryon Therapeutics NV (VVY) has a Financial Flexibility Index of -1.42x as of December 2025. Free cash flow of €-3.96 Million (operating CF €-3.96 Million minus capex €2.00K) represents -1% of total liabilities (€2.79 Million). Check Vivoryon Therapeutics NV tangible book value ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vivoryon Therapeutics NV Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Vivoryon Therapeutics NV across 15 annual periods. For the full cash flow conversion analysis, see Vivoryon Therapeutics NV operating cash flow efficiency.
Annual Financial Flexibility Index for Vivoryon Therapeutics NV (2011–2025)
Year-by-year free cash flow to debt coverage for Vivoryon Therapeutics NV. Explore Vivoryon Therapeutics NV cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.03x | €-8.45 Million | €-8.46 Million | €2.79 Million | ▲ +46.3% |
| 2024 | -5.63x | €-19.17 Million | €-19.17 Million | €3.40 Million | ▼ -21.8% |
| 2023 | -4.62x | €-21.03 Million | €-21.54 Million | €4.55 Million | ▼ -3.4% |
| 2022 | -4.47x | €-21.78 Million | €-21.79 Million | €4.87 Million | ▼ -217.0% |
| 2021 | -1.41x | €-11.23 Million | €-11.26 Million | €7.96 Million | ▲ +62.8% |
| 2020 | -3.79x | €-13.37 Million | €-14.01 Million | €3.53 Million | ▼ -4.7% |
| 2019 | -3.62x | €-11.56 Million | €-11.61 Million | €3.20 Million | ▼ -46.1% |
| 2018 | -2.48x | €-6.98K | €-6.99K | €2.82K | ▲ +62.4% |
| 2017 | -6.59x | €-12.11K | €-12.12K | €1.84K | ▼ -197.7% |
| 2016 | -2.21x | €-13.25K | €-13.26K | €5.99K | ▼ -4.4% |
| 2015 | -2.12x | €-12.14K | €-12.15K | €5.73K | ▼ -10.2% |
| 2014 | -1.92x | €-10.59K | €-10.59K | €5.51K | ▼ -140.7% |
| 2013 | -0.80x | €-8.46 Million | €-8.53 Million | €10.60 Million | ▲ +68.9% |
| 2012 | -2.57x | €-11.92 Million | €-12.04 Million | €4.64 Million | ▲ +25.1% |
| 2011 | -3.43x | €-14.22 Million | €-14.32 Million | €4.15 Million | — |